We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Restless Legs Drugs Need Black Box Warnings, FDA Hears

Law360, New York (June 15, 2017, 7:03 PM EDT) -- Several drugs for restless legs syndrome should get black box warnings that emphasize the risks of impulse-control disorders and other side effects, an industry-backed research company told the U.S. Food and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.